Findings from University of Toronto Broaden Understanding of Psoriatic Arthritis [Ixekizumab Treatment of Biologic-naive Patients With Active Psoriatic Arthritis: 3-year Results From a Phase Iii Clinical Trial (Spirit-p1)]

Source :: Immunotherapy Weekly. January 20, 2021, 1849
Publication Year :: 2021
Abstract: 2021 JAN 20 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Investigators publish new report on Autoimmune Diseases and Conditions - Psoriatic Arthritis. According to news [...]

Subjects :: Psoriatic arthritis -- Drug therapy -- Research
Immunotherapy -- Reports -- Research
Clinical trials -- Reports -- Research
Adalimumab -- Research -- Product development
Health
University of Toronto -- Reports

Tools